Variety, complexity and uncertainty in the therapy outcomes of cancer illness make the treatment recommendation (TR) in oncology a “monumentally difficult task”. Previous studies have distinguished unilateral and bilateral formats of treatment recommendations, accordingly to whether, or to what extent, the patient's perspective is included in the consideration of therapeutic options. Others have also shown how the oncologists' presentation of therapeutic options varied accordingly to the severity of the diagnosis and the availability of alternatives. Yet, no study has systemically dentified and compared components of treatment recommendation in oncology on a common set of patients and clinicians. This paper analyzes how different options in breast cancer treatments - radiotherapy, hormone therapy and chemotherapy - are presented and discussed in a set of 12 first post-surgical breast cancer visits carried out by two oncologists of high experience and seniority in two Italian hospitals. Treatment recommendation sequences involving these three option types were analyzed using the methods of conversation analysis. They were also coded for the mention of side effects and treatment burden, and for whether consent to the recommendation was invited, or expressed by the patient. Results show that radiotherapy is presented as presupposed as an extension of surgery and is not further discussed, and hormone therapy is delivered as good news and as not implying any health or lifestyle burdens. Treatment burdens were raised in the much more extensive discussions of chemotherapy, which were also accompanied by a higher chance that the patient was asked for consent to therapy. Implications are drawn as regards the extent to which clinical practice meets theory in communication protocols available in oncology, and how to consider the doctor-patient partnership and the concept of shared decision-making in such an encounter.
Presenting treatment options in breast cancer consultations: Advice and consent in Italian medical care / Fatigante, M.; Heritage, J.; Alby, F.; Zucchermaglio, C.. - In: SOCIAL SCIENCE & MEDICINE. - ISSN 0277-9536. - 266(2020), p. 113175.
Scheda prodotto non validato
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
|Titolo:||Presenting treatment options in breast cancer consultations: Advice and consent in Italian medical care|
FATIGANTE, Marilena (Primo)
HERITAGE, John Cristopher (Secondo)
ALBY, Francesca (Penultimo)
ZUCCHERMAGLIO, Cristina (Ultimo)
|Data di pubblicazione:||2020|
|Citazione:||Presenting treatment options in breast cancer consultations: Advice and consent in Italian medical care / Fatigante, M.; Heritage, J.; Alby, F.; Zucchermaglio, C.. - In: SOCIAL SCIENCE & MEDICINE. - ISSN 0277-9536. - 266(2020), p. 113175.|
|Appartiene alla tipologia:||01a Articolo in rivista|